COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,552 Articles (22,881 medRxiv, 8,671 bioRxiv)

Most recent first Previous |  Page 1094: Articles 10931-10940  | Next

The impact of environmental mycobiomes on geographic variation in COVID-19 mortality
Ladau, J., Abuabara, K., Walker, A. M., Joachimiak, M. P., Bansal, I., Wu, Y., Hoffman, E. B., Kuo, C., Falco, N., Streich, J., van der Lan, M. J., Wainwright, H. M., Brodie, E. L., Hess, M., Jacobson, D. A., Brown, J. B.
10.1101/2021.12.14.21267549 — Posted: 2021-12-16
A systematic literature review of individual-level psychological and behavioral responses to the health information of COVID-19 from social media and legacy media
Zhai, W., Bian, J., Zhang, J., Bai, X.
10.1101/2021.12.14.21267757 — Posted: 2021-12-16
Early detection and improved genomic surveillance of SARS-CoV-2 variants from deep sequencing data
Ramazzotti, D., Maspero, D., Angaroni, F., Antoniotti, M., Piazza, R., Graudenzi, A.
10.1101/2021.12.14.21267810 — Posted: 2021-12-16
Emerging from the COVID-19 pandemic: impacts of variants, vaccines, and duration of immunity
Newcomb, K., Michael, E.
10.1101/2021.12.14.21267804 — Posted: 2021-12-15
Transmission of SARS-CoV-2 by children and young people in households and schools: a meta-analysis of population-based and contact-tracing studies
Viner, R. M., Waddington, C., Mytton, O., Booy, R., Cruz, J., Ward, J., Ladhani, S., Panovska-Griffiths, J., Bonell, C., Melendez-Torres, G. J.
10.1101/2021.12.14.21267713 — Posted: 2021-12-15
Performances of community pharmacists and community pharmacies during COVID-19 outbreak: a cross-sectional study
Sadeghinejad, A., Nikvarz, N.
10.1101/2021.12.14.21267818 — Posted: 2021-12-15
Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England
Westrop, S. J., Whitaker, H. J., Powell, A. A., Power, L., Whillock, C., Campbell, H., Simmons, R., Warrener, L., Ramsay, M. E., Ladhani, S. N., Brown, K. E., Amirthalingham, G.
10.1101/2021.12.14.21267562 — Posted: 2021-12-15
Global epidemiology of SARS-CoV-2 infection: a systematic review and meta-analysis of standardized population-based seroprevalence studies, Jan 2020-Oct 2021
Bergeri, I., Whelan, M., Ware, H., Subissi, L., Nardone, A., Lewis, H. C., Li, Z., Ma, X., Valenciano, M., Cheng, B., Al Ariqi, L., Rashidian, A., Okeibunor, J., Azim, T., Wijesinghe, P., Le, L.-V., Vaughan, A., Pebody, R., Vicari, A., Yan, T., Yanes-Lane, M., Cao, C., Cheng, M. P., Papenburg, J., Buckeridge, D., Bobrovitz, N., Arora, R. K., van Kerkhove, M. D., Unity Studies Collaborator Group
10.1101/2021.12.14.21267791 — Posted: 2021-12-15
Final sizes and durations of new COVID-19 pandemic waves in Poland and Germany predicted by generalized SIR model
Nesteruk, I.
10.1101/2021.12.14.21267771 — Posted: 2021-12-15
Differential Risk of SARS-CoV-2 Infection by Occupation: Evidence from the Virus Watch prospective cohort study in England and Wales
Beale, S., Hoskins, S. J., Byrne, T. E., Fong, E. W. L., Fragaszy, E., Geismar, C., Kovar, J., Navaratnam, A. M., Nguyen, V., Patel, P., Yavlinsky, A., Johnson, A., Aldridge, R. W., Hayward, A.
10.1101/2021.12.14.21267460 — Posted: 2021-12-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).